CCL PRODUCTS (INDIA)
|
|
BOM : 519600     NSE : CCL     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
Oct 04,2024 |
Price(EOD): ₹ 668.95
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Tea/Coffee |
MCap: ₹ 8,930.48 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
CCL PRODUCTS (INDIA) | -5.9% | -15.4% | 1.2% |
TATA CONSUMER PRODUCTS | -7.1% | -6.4% | 31.2% |
ANDREW YULE & COMPANY | -5.4% | -15.4% | 25.7% |
GOODRICKE GROUP | 1.9% | -0.4% | 37% |
JAY SHREE TEA & INDUSTRIES | 0.8% | 0.1% | 37.2% |
MCLEOD RUSSEL INDIA | 1.8% | 25.3% | 65.3% |
FUNDAMENTAL ANALYSIS OF CCL PRODUCTS (INDIA)
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF CCL PRODUCTS (INDIA)
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
34.25
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 260.84 Cr
[Latest Qtr - Jun2024 - Consolidated Results ] 5.39
P/B Calculated based on Book Value of Rs 1,656.96 Cr
[Latest Year - Mar2024 - Consolidated Results ] 3.22
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 2,772.06 Cr
[Latest Qtr - Jun2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
126% 12% 7% |
SHARE PRICE MOMENTUM OF CCL PRODUCTS (INDIA)
CCL PRODUCTS (INDIA) vs SENSEX
DEBT OF CCL PRODUCTS (INDIA)
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.71 0.54 0.48 0.58 |
0.98 0.62 0.52 0.71 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF CCL PRODUCTS (INDIA)
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF CCL PRODUCTS (INDIA)
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
6.41% 10.29% 23.81% 9.58% |
18.07% 22.54% 25.58% 17.72% |
QtrlyTrend |
8 | |
Latest Qtr: Jun2024 | ||
Quarterly Result Analysis → |
CCL PRODUCTS (INDIA) related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE FMCG | -4.4% | -1.9% | 22.3% |
S&P BSE 250 SMALLCAP | -4.6% | -4.1% | 41.1% |
S&P BSE 400 MIDSMALLCAP | -5% | -3.5% | 42.9% |
S&P BSE MIDSMALLCAP | -5.1% | -3.9% | 44.8% |
S&P BSE SMALL CAP | -5.2% | -3.7% | 44.1% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY SMALLCAP250 | -4.8% | -4.4% | 43.2% |
NIFTY MID SMALL400 | -4.9% | -3.4% | 41.4% |
NIFTY500 MULTICAP 50:25:25 | -5.2% | -2.8% | 36.7% |
NIFTY 500 | -5.3% | -2.4% | 34.1% |
You may also like the below Video Courses
FAQ about CCL PRODUCTS (INDIA)
Is CCL PRODUCTS (INDIA) good for long term investment?
As on Oct 04,2024, the Fundamentals of CCL PRODUCTS (INDIA) look Strong and hence it may be good for long term investment! See Financial Performance of CCL PRODUCTS (INDIA) . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is CCL PRODUCTS (INDIA) UnderValued or OverValued?
As on Oct 04,2024, CCL PRODUCTS (INDIA) is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of CCL PRODUCTS (INDIA) ?
As on Oct 04,2024, the Intrinsic Value of CCL PRODUCTS (INDIA) is Rs. 595.87 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 296.42
Fair Value [Median EV / Sales Model] : Rs. 595.87
Fair Value [Median Price / Sales Model] : Rs. 625.73
Estimated Median Fair Value of CCL PRODUCTS (INDIA) : Rs. 595.87
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.